PCSK9 and hyperthyroidism: Also consistent with the findings in hyperthyroidism, eprotirome treatment was associated with markedly reduced (−25%) levels of Lp(a) (supplementary Table II) as well as PCSK9 (−17%) (Fig. 3E).